Study of gut response to a diabetes pill in adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how your body responds to a new diabetes pill, orforglipron, by looking at hormones and blood sugar. The results may help doctors choose the best treatment for people with type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult aged 18 to 79.
- You may have type 2 diabetes, but if you do, you are taking no more than two diabetes pills by mouth.
- You are willing to stop your diabetes pills for 5 days before the study, with your doctor's approval.
- You do not have certain health conditions like problems with your pancreas, gallbladder, liver, or kidneys.
- Your most recent blood sugar test (HbA1c) is 7.5% or lower.
- You are not currently taking insulin, GLP-1 injections, or other diabetes medicines that are not pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication called orforglipron to see if it safely helps people with type 2 diabetes manage their blood sugar while they fast during Ramadan. You may be a good fit if you are planning to fast and your diabetes is not too severe.
This study tests an experimental daily pill (orforglipron) against an approved weekly injection (dulaglutide) in young people with type 2 diabetes. It aims to see which works better at controlling blood sugar and may offer a more convenient option.
This study tests an investigational medication, orforglipron, taken as a pill to help people with excess weight lose weight. It may be an option for people who have not been able to lose weight with diet alone and who also have weight-related health problems.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Hear when a new Pharmacogenomic Drug Interaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.